US equities
|
MU
$1,070.02
▲+0.46%
NVDA
$230.38
▲+0.88%
SNDK
$1,778.17
▲+2.20%
GOOGL
$337.85
▼-1.81%
TSLA
$355.81
▲+0.28%
INTC
$120.50
▲+0.22%
SPCX
$149.92
▼-0.63%
AMD
$613.40
▲+0.27%
MU
$1,070.02
▲+0.46%
NVDA
$230.38
▲+0.88%
SNDK
$1,778.17
▲+2.20%
GOOGL
$337.85
▼-1.81%
TSLA
$355.81
▲+0.28%
INTC
$120.50
▲+0.22%
SPCX
$149.92
▼-0.63%
AMD
$613.40
▲+0.27%
FinancialContent
Watchlist
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
My watchlist
My portfolio
Recent quotes
Puma Biotechnology Inc - Common Stock
(NQ:
PBYI
)
10.01
+0.08 (+0.76%)
Delayed Quote
Updated: 1:15 PM EDT, Oct 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Puma Biotechnology Inc - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
↗
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Puma Biotechnology to Host Conference Call to Discuss First Quarter Financial Results
April 22, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
April 13, 2021
From
Puma Biotechnology, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >